ZYXI - Zynex, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.5000
0.0000 (0.00%)
At close: 4:00PM EDT

4.5000 0.00 (0.00%)
After hours: 4:00PM EDT

Stock chart is not supported by your current browser
Previous Close4.5000
Open4.4600
Bid0.4000 x 1800
Ask4.6700 x 800
Day's Range4.4510 - 4.5000
52 Week Range2.4000 - 5.9000
Volume11,924
Avg. Volume39,636
Market Cap145.071M
Beta (3Y Monthly)1.94
PE Ratio (TTM)16.07
EPS (TTM)0.2800
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2018-12-31
1y Target Est7.58
Trade prices are not sourced from all markets
  • Zynex Reactivates Medicare Provider Number in Effort to Accelerate Growth
    PR Newswire3 days ago

    Zynex Reactivates Medicare Provider Number in Effort to Accelerate Growth

    ENGLEWOOD, Colo., March 19, 2019 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has reactivated its Medicare Provider Number in an effort to also bill Medicare on behalf of its patients. Thomas Sandgaard, CEO said: "We continue to expand our sales force and geographic footprint across the US and have decided to reactivate our Medicare provider number. Medicare continues to approve of and pay for our prescription strength pain management technology.

  • Zynex Expands Corporate Headquarters to Accommodate Growth
    PR Newswire10 days ago

    Zynex Expands Corporate Headquarters to Accommodate Growth

    ENGLEWOOD, Colo., March 12, 2019 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has signed an addendum to its corporate headquarters building lease expanding the footprint to 63,000 square feet, a 50% increase. Thomas Sandgaard, CEO said: "Our order and revenue growth has put pressure on expanding our corporate headquarters and we are fortunate to have a Right of First Refusal to add additional space with our existing building.

  • ACCESSWIRE10 days ago

    LD Micro Virtual Conference Is Live, March 12th and 13th

    LOS ANGELES, CA / ACCESSWIRE / March 12 , 2019 / LD Micro, a company that puts on conferences for micro-cap and small-cap companies will be hosting 46 companies on March 12th (that's today) and 13th, starting ...

  • ACCESSWIRE16 days ago

    Zynex to Present at the 2019 LD Micro Virtual Conference

    LOS ANGELES, CA / ACCESSWIRE / March 6, 2019 / Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it will be presenting at the second annual LD Micro Virtual Conference on Tuesday, March 12 at 2 PM EST. Thomas Sandgaard, CEO of Zynex will be giving the presentation and answering questions from investors. "We are delighted to be hosting our second virtual event in order to showcase some of the truly unique names in micro-cap" stated Chris Lahiji, President of LD Micro.

  • What Should Investors Know About Zynex, Inc.’s (NASDAQ:ZYXI) Future?
    Simply Wall St.19 days ago

    What Should Investors Know About Zynex, Inc.’s (NASDAQ:ZYXI) Future?

    The most recent earnings announcement Zynex, Inc.'s (NASDAQ:ZYXI) released in December 2018 signalled that the company benefited from a robust tailwind, eventuating to a double-digit earnings growth of 30%. TodayRead More...

  • Thomson Reuters StreetEvents21 days ago

    Edited Transcript of ZYXI earnings conference call or presentation 26-Feb-19 9:15pm GMT

    Q4 2018 Zynex Inc Earnings Call

  • Zynex names new Vice President of Sales and Marketing
    PR Newswire22 days ago

    Zynex names new Vice President of Sales and Marketing

    ENGLEWOOD, Colo., Feb. 28, 2019 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has hired Christopher A. Brown as its Vice President of Sales and Marketing. Chris Brown has spent his entire career in sales and marketing in the healthcare industry including start-ups, venture backed and publicly traded companies. Chris has in his career held Vice President positions with Safeop Surgical, Nuvasive/Impulse Monitoring, Intelistaff Healthcare and Steris Corp/AMSCO.

  • Zynex Announces 2018 Fourth Quarter and Full Year Earnings
    PR Newswire24 days ago

    Zynex Announces 2018 Fourth Quarter and Full Year Earnings

    2018 Full Year - Revenue increased 36% year over year to $31.9 million - Net income increased 30% to $9.6 million ; Diluted EPS $0.28 - Adjusted EBITDA $10.9M 2018 Fourth Quarter - Revenue increased 15% ...

  • Zynex Schedules 2018 and Fourth Quarter Earnings
    PR Newswirelast month

    Zynex Schedules 2018 and Fourth Quarter Earnings

    ENGLEWOOD, Colo., Feb. 20, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, ...

  • Zynex to Ring the Nasdaq Stock Market Opening Bell to Celebrate Its Listing
    PR Newswirelast month

    Zynex to Ring the Nasdaq Stock Market Opening Bell to Celebrate Its Listing

    The ceremony commemorates Zynex's listing on the Nasdaq Capital Market on February 21, 2019. Thomas Sandgaard, Founder, Chairman and CEO is pleased to celebrate alongside Zynex's Board of Directors and members of the executive team honoring the Company's milestone achievement.

  • Should You Be Holding Zynex, Inc. (NASDAQ:ZYXI)?
    Simply Wall St.last month

    Should You Be Holding Zynex, Inc. (NASDAQ:ZYXI)?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Building up an investment case requires lookingRead More...

  • Zynex Announces Uplisting to The Nasdaq Capital Market
    PR Newswirelast month

    Zynex Announces Uplisting to The Nasdaq Capital Market

    ENGLEWOOD, Colo., Feb. 7, 2019 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, is pleased to announce that its common shares have been approved to list on The Nasdaq Capital Market and is expected to begin trading under its existing symbol (ZYXI) on February 12, 2019. "We are excited to reach this important milestone for Zynex.

  • ACCESSWIRE4 months ago

    Zynex to Present at the 11th Annual LD Micro Main Event

    LOS ANGELES, CA / ACCESSWIRE / November 20, 2018 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it will be presenting at the 11th annual LD Micro Main Event on Tuesday, December 4th at 4:30pm PST / 7:30pm EST. Zynex's CEO, Thomas Sandgaard will be presenting and meeting with investors. The LD Micro Main Event will take place December 4th, 5th, and 6th, in Los Angeles at the Luxe Sunset Bel Air Hotel, will feature 250 companies, and will be attended by over 1,200 individuals.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of ZYXI earnings conference call or presentation 6-Nov-18 4:00pm GMT

    Q3 2018 Zynex Inc Earnings Call

  • Zynex Announces 2018 Third Quarter Earnings and Special Dividend
    PR Newswire4 months ago

    Zynex Announces 2018 Third Quarter Earnings and Special Dividend

    - Revenue increased 19% year over year to $8.1 million - Net income of $2.6 million increased 18% year over year; Diluted EPS $0.08 - Adjusted EBITDA of $3.0 million - Board of Directors declares a one-time ...

  • Zynex Schedules 2018 Third Quarter Earnings Release and Webcast
    PR Newswire5 months ago

    Zynex Schedules 2018 Third Quarter Earnings Release and Webcast

    ENGLEWOOD, Colo. , Nov. 2, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, ...

  • Zynex Obtains U.S. Patent for Blood Volume Monitor
    PR Newswire5 months ago

    Zynex Obtains U.S. Patent for Blood Volume Monitor

    ENGLEWOOD, Colo., Oct. 8, 2018 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announces that it has obtained a U.S. utility patent for its Blood Volume Monitor Device. Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of ZYXI earnings conference call or presentation 8-May-18 3:00pm GMT

    Q1 2018 Zynex Inc Earnings Call

  • Zynex to Present at the Ladenburg Thalmann 2018 Healthcare Conference
    PR Newswire6 months ago

    Zynex to Present at the Ladenburg Thalmann 2018 Healthcare Conference

    ENGLEWOOD, Colo., Sept. 25, 2018 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, and neurological diagnostics, today announced that Thomas Sandgaard, Chief Executive Officer of Zynex, will be presenting at the Ladenburg Thalmann 2018 Healthcare Conference, on Tuesday October 2, 2018 at 2:30 pm EDT.  The conference will be held at the Sofitel Hotel in New York City.

  • Zynex to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
    PR Newswire7 months ago

    Zynex to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

    Thomas Sandgaard, Chief Executive Officer of Zynex, will provide an overview of the Company's business in a presentation scheduled on Thursday, September 6, 2018 at 12:05 pm EDT. Management will also be meeting with members of the investment community during one-on-one meetings.

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of ZYXI earnings conference call or presentation 2-Aug-18 5:00pm GMT

    Q2 2018 Zynex Inc Earnings Call

  • ACCESSWIRE7 months ago

    SeeThruEquity Issues Update on Zynex, Inc.

    NEW YORK, NY / ACCESSWIRE / August 16, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has ...

  • ACCESSWIRE7 months ago

    Consilium Global Research Issues Quarterly Update on Zynex, Inc (OTCQB: ZYXI)

    ST. PETERSBURG, FL / ACCESSWIRE / August 10, 2018 / Consilium Global Research (CGR) an Investor Recognition Company that connects Companies with Investors, today announced that it has issued an Update ...

  • Zynex Announces 2018 Second Quarter Earnings
    PR Newswire8 months ago

    Zynex Announces 2018 Second Quarter Earnings

    - Revenue increased 50% year over year to $7.6 million - Net income of $2.4 million increased 61% year over year; Diluted EPS $0.07 - Adjusted EBITDA of $2.8 million increased 41% year over year - Eighth ...

  • Zynex Schedules 2018 Second Quarter Earnings Release and Webcast
    PR Newswire8 months ago

    Zynex Schedules 2018 Second Quarter Earnings Release and Webcast

    LONE TREE, Colo. , July 27, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, ...